Below is our "Chart of the Day" from today's Early Look written by our Risk-Manager-In-Chief Keith McCullough detailing Health Care analyst Tom Tobin's EPIC short call on 10x Genomics (TXG).
TXG missed 3Q24 earnings this morning sending the stock plummeting -26% in pre-market trading.
Tobin has been short TXG since March 2022, riding it down from $70 after being bullish on its way up to $202 in 2021.
According to Tobin, "The worst part hasn't even happened yet." CLICK HERE to get more Health Care research and follow all new developments.
